Filter news by date News Tags - Any -News storyPress release Month MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Year Year2024202320222021202020192018201720162015201420132012201120102009200820072006 Apply 2 . 2 . 2024 Press release Galderma celebrates 25 years of excellence in biostimulation with Sculptra® at the 2024 IMCAS 1 . 29 . 2024 News story The remarkable journey of Restylane, from the lab to the patient 1 . 25 . 2024 Press release IMCAS 2024: Galderma to present latest updates from its unparalleled aesthetics portfolio reinforcing its leadership position 1 . 25 . 2024 News story IMCAS 2024: Galderma’s scientific presentations 1 . 22 . 2024 Collaborative growth 1 . 22 . 2024 Press release Galderma announces regulatory approval for Restylane® SHAYPE™, a new hyaluronic acid injectable designed for augmenting the chin region 1 . 17 . 2024 News story TOXINS 2024: Galderma’s poster presentations 1 . 17 . 2024 Press release TOXINS 2024: Galderma’s phase III RelabotulinumtoxinA results demonstrate positive efficacy and long duration of effect when treating frown lines and crow’s feet simultaneously 12 . 15 . 2023 News story A common purpose 12 . 7 . 2023 News story Centering patient needs: Dr. Shridharani's shared values with Galderma 11 . 30 . 2023 Press release Results from Galderma’s phase IIIb trials demonstrate rapid and long-lasting effect of RelabotulinumtoxinA on crow’s feet and frown lines 11 . 27 . 2023 News story Our culture Pagination Previous page Previous Page Next page Next Page